Data capture and sharing in the COVID-19 pandemic: a cause for concern

L Dron, V Kalatharan, A Gupta, J Haggstrom… - The Lancet Digital …, 2022 - thelancet.com
Routine health care and research have been profoundly influenced by digital-health
technologies. These technologies range from primary data collection in electronic health …

Industry involvement and transparency in the most cited clinical trials, 2019-2022

LM Siena, L Papamanolis, MJ Siebert… - JAMA Network …, 2023 - jamanetwork.com
Importance Industry involvement is prominent in influential clinical trials, and commitments to
transparency of trials are highly variable. Objective To evaluate the modes of industry …

[HTML][HTML] Implementation of platform trials in the COVID-19 pandemic: a rapid review

AM Vanderbeek, JM Bliss, Z Yin, C Yap - Contemporary Clinical Trials, 2022 - Elsevier
Motivation Platform designs-master protocols that allow for new treatment arms to be added
over time-have gained considerable attention in recent years. Between 2001 and 2019, 16 …

[HTML][HTML] Investigating linkages between spatiotemporal patterns of the COVID-19 Delta variant and public health interventions in Southeast Asia: prospective space …

W Luo, Z Liu, Y Zhou, Y Zhao, YE Li… - JMIR Public Health …, 2022 - publichealth.jmir.org
Background: The COVID-19 Delta variant has presented an unprecedented challenge to
countries in Southeast Asia (SEA). Its transmission has shown spatial heterogeneity in SEA …

Identification and development of therapeutics for COVID-19

HM Rando, N Wellhausen, S Ghosh, AJ Lee… - Msystems, 2021 - Am Soc Microbiol
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …

Transparency of COVID-19-related research in dental journals

A Sofi-Mahmudi, E Raittio - Frontiers in oral health, 2022 - frontiersin.org
Objective We aimed to assess the adherence to transparency practices (data availability,
code availability, statements of protocol registration and conflicts of interest and funding …

Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?

J Mandema, H Montgomery, L Dron… - Clinical and …, 2023 - Wiley Online Library
Rapid and robust strategies to evaluate the efficacy and effectiveness of novel and existing
pharmacotherapeutic interventions (repurposed treatments) in future pandemics are …

[HTML][HTML] Improving Participant Recruitment in Clinical Trials: Comparative Analysis of Innovative Digital Platforms

AG Bikou, E Deligianni, F Dermiki-Gkana… - Journal of Medical …, 2024 - jmir.org
Background Pharmaceutical product development relies on thorough and costly clinical
trials. Participant recruitment and monitoring can be challenging. The incorporation of cutting …

Global Trend on Machine Learning in Helicobacter within One Decade: A Scientometric Study

O Eslami, M Nakhaie, MRZ Rukerd, M Azimi… - Global Health …, 2023 - cambridge.org
Purpose. This study aims to create a science map, provide structural analysis, investigate
evolution, and identify new trends in Helicobacter pylori (H. pylori) research articles …

[HTML][HTML] Now is the time to strengthen government-academic data infrastructures to jump-start future public health crisis response

JS Lee, ARB Tyler, TC Veinot, E Yakel - JMIR public health and …, 2024 - jmir.org
During public health crises, the significance of rapid data sharing cannot be overstated. In
attempts to accelerate COVID-19 pandemic responses, discussions within society and …